Clinical Trial Update: Docetaxel and Diethylstilbestrol in the Treatment of Androgen Independent Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial at the University of Washington evaluated the combination of docetaxel and diethylstilbestrol in androgen-independent prostate cancer. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Diethylstilbestrol (diethylstilbestrol)

Snippet

Sponsor: University of Washington | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED